Kathy L. Poulin

Family Medicine

2203 W 35th St
Austin State Supported Living Center
Austin, TX 78703

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy.

Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy.

Journal: Molecular therapy. Advances

Published: September 26, 2025

Development and Characterization of an Oncolytic Human Adenovirus-Based Vector Co-Expressing the Adenovirus Death Protein and p14 Fusion-Associated Small Transmembrane Fusogenic Protein.

Development and Characterization of an Oncolytic Human Adenovirus-Based Vector Co-Expressing the Adenovirus Death Protein and p14 Fusion-Associated Small Transmembrane Fusogenic Protein.

Journal: International journal of molecular sciences

Published: November 06, 2024

Liver SMN restoration rescues the Smn2B/- mouse model of spinal muscular atrophy.

Liver SMN restoration rescues the Smn2B/- mouse model of spinal muscular atrophy.

Journal: EBioMedicine

Published: May 14, 2024

Label-free quantitative proteomic analysis of extracellular vesicles released from fibroblasts derived from patients with spinal muscular atrophy.

Label-free quantitative proteomic analysis of extracellular vesicles released from fibroblasts derived from patients with spinal muscular atrophy.

Journal: Proteomics

Published: November 25, 2020

Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity.

Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity.

Journal: Journal of virology

Published: June 02, 2020

The genome position of a therapeutic transgene strongly influences the level of expression in an armed oncolytic human adenovirus vector.

The genome position of a therapeutic transgene strongly influences the level of expression in an armed oncolytic human adenovirus vector.

Journal: Virology

Published: March 05, 2020

Human adenoviral DNA association with nucleosomes containing histone variant H3.3 during the early phase of infection is not dependent on viral transcription or replication.

Human adenoviral DNA association with nucleosomes containing histone variant H3.3 during the early phase of infection is not dependent on viral transcription or replication.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: June 07, 2018

Survival Motor Neuron Protein is Released from Cells in Exosomes: A Potential Biomarker for Spinal Muscular Atrophy.

Survival Motor Neuron Protein is Released from Cells in Exosomes: A Potential Biomarker for Spinal Muscular Atrophy.

Journal: Scientific reports

Published: May 30, 2017

Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer.

Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer.

Journal: Cancer gene therapy

Published: April 13, 2016

Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer.

Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer.

Journal: PloS one

Published: December 23, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026